Aurinia Pharmaceuticals (AUPH) Net Margin Growth (1y) (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 684.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 684.00 |
| Dec 31, 2025 | 27,089.00 |
| Sep 30, 2025 | 2,185.00 |
| Jun 30, 2025 | 2,953.00 |
| Mar 31, 2025 | 5,866.00 |
| Dec 31, 2024 | 6,205.00 |
| Sep 30, 2024 | 4,578.00 |
| Jun 30, 2024 | 2,896.00 |
| Mar 31, 2024 | 5,487.00 |
| Dec 31, 2023 | 3,192.00 |
| Sep 30, 2023 | -855.00 |
| Jun 30, 2023 | 9,828.00 |
| Mar 31, 2023 | 9,785.00 |
| Dec 31, 2022 | 5,088.00 |
| Sep 30, 2022 | 32,652.00 |
| Jun 30, 2022 | 58,414.00 |
| Mar 31, 2022 | 533,791.00 |
| Dec 31, 2021 | -12,624.00 |
| Sep 30, 2021 | 14.49 Mn |
| Jun 30, 2021 | 9.08 Mn |